IDH3A and glioblastoma: The analysis carried out by [33] to predict the isocitrate dehydrogenase (IDH) mutation in patients with GBM using magnetic resonance imaging, employing a convolution neural network, showed a maximum accuracy of 77% in fluid-attenuated inversion recovery (FLAIR) images, highlighting the potential use of these techniques in the personalization of the treatment.